Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
NCT ID: NCT05399615
Last Updated: 2023-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2022-12-30
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of COVID-19 Using Breath Analysis - Validation Study.
NCT05224622
Detection of COVID-19 Using Breath Analysis - Validation Study
NCT04602949
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
NCT04842708
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective: To identify a set of breath Volatile Organic Compound biomarkers that enable the detection of pathogens infection and inflammatory response to pathogens infection among hospitalized patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized Patients
Patients hospitalized in internal ward at "Poriya" Medical Center
VOX
Breath biopsy
Controls
Healthy volunteers
VOX
Breath biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VOX
Breath biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of understanding written and/or spoken language
* Able to provide informed consent
* Negative results for SARS-CoV-2
* Diagnosed with suspected respiratory infection
Exclusion Criteria
* Pregnant or lactating woman
* Not able to breathe through mask for 8 minutes
* Intubated patients
* Patients in critical condition
* Diagnosed with hospital-acquired infection
* Medical history of malignancies
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scentech Medical Technologies Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Avi Peretz, PhD
Role: PRINCIPAL_INVESTIGATOR
Poriya Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poriya Medical Center
Poria – Neve Oved, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-PMC-2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.